Domain binding and isotype dictate the activity of anti-human OX40 antibodies.
Griffiths J, Hussain K, Smith HL, Sanders T, Cox KL, Semmrich M, Mårtensson L, Kim J, Inzhelevskaya T, Penfold CA, Tutt AL, Mockridge CI, Chan HC, English V, French RF, Teige I, Al-Shamkhani A, Glennie MJ, Frendeus BL, Willoughby JE, Cragg MS.
Griffiths J, et al. Among authors: cragg ms.
J Immunother Cancer. 2020 Dec;8(2):e001557. doi: 10.1136/jitc-2020-001557.
J Immunother Cancer. 2020.
PMID: 33428585
Free PMC article.